Su1773 ACHIEVEMENT OF CLINICAL AND ENDOSCOPIC OUTCOMES BY BASELINE CORTICOSTEROID USE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RECEIVED RISANKIZUMAB INDUCTION TREATMENT: A POST-HOC ANALYSIS OF THE INSPIRE STUDY

Autor: Bossuyt, Peter, Louis, Edouard, Gecse, Krisztina, Abreu, Maria T., Gionchetti, Paolo, Rubin, David T., Marced, Elena, Gonzalez, Yuri Sanchez, Hecht, Patrick, Kalabic, Jasmina, Vladea, Ramona C., Zhang, Yafei, Reinisch, Walter
Zdroj: In Gastroenterology 18-21 May 2024 166(5) Supplement:S
Databáze: ScienceDirect